Clinical Trials Browser

Phase 2 × Hepatectomy × 90 days × Clear all

NCT05349331 2026-01-15

WATCH

Phase 2 Completed

Gastrointestinal

Conversion Disorder, Carcinoma, Hepatocellular

NCT03844750 2025-12-31

Preoperative Immunotherapy (Pembrolizumab) for Patients With Colorectal Cancer and Resectable Hepatic Metastases

Phase 2 Terminated

6 enrolled 12 charts

Gastrointestinal

Colorectal Neoplasms